Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele

被引:70
作者
Huang, Xinyan
Fu, Ying
Charbeneau, Raelene A.
Saunders, Thomas L.
Taylor, Douglas K.
Hankenson, Kurt D.
Russell, Mark W.
D'Alecy, Louis G.
Neubig, Richard R.
机构
[1] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Transgen Anim Model Core, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA
[7] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA
[8] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
[9] Univ Michigan, Dept Vasc Surg, Ann Arbor, MI 48109 USA
[10] William Beaumont Hosp, Dept Surg, Royal Oak, MI 48072 USA
关键词
D O I
10.1128/MCB.00314-06
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signal transduction via guanine nucleotide binding proteins (G proteins) is involved in cardiovascular, neural, endocrine, and immune cell function. Regulators of G protein signaling (RGS proteins) speed the turn-off of G protein signals and inhibit signal transduction, but the in vivo roles of RGS proteins remain poorly defined. To overcome the redundancy of RGS functions and reveal the total contribution of RGS regulation at the G alpha(i2) subunit, we prepared a genomic knock-in of the RGS-insensitive G184S Gnai2 allele. The G alpha(G184S)(i2) knock-in mice show a dramatic and complex phenotype affecting multiple organ systems (heart, myeloid, skeletal, and central nervous system). Both homozygotes and heterozygotes demonstrate reduced viability and decreased body weight. Other phenotypes include shortened long bones, a markedly enlarged spleen, elevated neutrophil counts, an enlarged heart, and behavioral hyperactivity. Heterozygous G alpha(+/G184S)(i2) mice show some but not all of these abnormalities. Thus, loss of RGS actions at G alpha(i2) produces a dramatic and pleiotropic phenotype which is more evident than the phenotype seen for individual RGS protein knockouts.
引用
收藏
页码:6870 / 6879
页数:10
相关论文
共 72 条
[11]   Endogenous RGS protein action modulates μ-opioid signaling through Gαo -: Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways [J].
Clark, MJ ;
Harrison, C ;
Zhong, HL ;
Neubig, RR ;
Traynor, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9418-9425
[12]   Endogenous regulator of G protein signaling proteins suppress Gαo-dependent, μ-opioid agonist-mediated adenylyl cyclase supersensitization [J].
Clark, MJ ;
Neubig, RR ;
Traynor, JR .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (01) :215-222
[13]   Endogenous regulator of G protein signaling proteins reduce μ-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells [J].
Clark, MJ ;
Traynor, JR .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (02) :809-815
[14]   Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice [J].
Condorelli, G ;
Drusco, A ;
Stassi, G ;
Bellacosa, A ;
Roncarati, R ;
Iaccarino, G ;
Russo, MA ;
Gu, YS ;
Dalton, N ;
Chung, C ;
Latronico, MVG ;
Napoli, C ;
Sadoshima, J ;
Croce, CM ;
Ross, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12333-12338
[15]   Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span [J].
Coschigano, KT ;
Holland, AN ;
Riders, ME ;
List, EO ;
Flyvbjerg, A ;
Kopchick, JJ .
ENDOCRINOLOGY, 2003, 144 (09) :3799-3810
[16]   B cell developmental requirement for the Gαi2 gene [J].
Dalwadi, H ;
Wei, B ;
Schrage, M ;
Su, TT ;
Rawlings, DJ ;
Braun, J .
JOURNAL OF IMMUNOLOGY, 2003, 170 (04) :1707-1715
[17]   Ion-channel regulation by G proteins [J].
Dascal, N .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (09) :391-398
[18]   Characterization of the GRK2 binding site of Gαq [J].
Day, PW ;
Tesmer, JJG ;
Sterne-Marr, R ;
Freeman, LC ;
Benovic, JL ;
Wedegaertner, PB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (51) :53643-53652
[19]   Selective uncoupling of RGS action by a single point mutation in the G protein α-subunit [J].
DiBello, PR ;
Garrison, TR ;
Apanovitch, DM ;
Hoffman, G ;
Shuey, DJ ;
Mason, K ;
Cockett, MI ;
Dohlman, HG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) :5780-5784
[20]   Is RGS-2 a new drug development target in cardiovascular disease? [J].
Doggrell, SA .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2004, 8 (04) :355-358